Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 106 AL 120

PUBMED

Habitual behavior and dopamine cell vulnerability in Parkinson disease.

Hernández LF, Redgrave P, Obeso JA.

Front Neuroanat. 2015 Aug 6;9:99. doi: 10.3389/fnana.2015.00099. No abstract available. Erratum in: Front Neuroanat. 2015;9:146.

0

0

0

PUBMED

A long-term study of istradefylline safety and efficacy in patients with Parkinson disease.

Kondo T, Mizuno Y; Japanese Istradefylline Study Group..

Clin Neuropharmacol. 2015 Mar-Apr;38(2):41-6. doi: 10.1097/WNF.0000000000000073.

0

0

0

PUBMED

Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.

Labandeira-Garcia JL, Rodríguez-Perez AI, Villar-Cheda B, Borrajo A, Dominguez-Meijide A, Guerra MJ.

Neuroscientist. 2015 Dec;21(6):616-29. doi: 10.1177/1073858414554954. Review.

0

0

0

PUBMED

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group., Ebersbach G.

J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x.

0

0

0

PUBMED

LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease.

Tyurina YY, Polimova AM, Maciel E, Tyurin VA, Kapralova VI, Winnica DE, Vikulina AS, Domingues MR, McCoy J, Sanders LH, Bayır H, Greenamyre JT, Kagan VE.

Free Radic Res. 2015 May;49(5):681-91. doi: 10.3109/10715762.2015.1005085.

0

0

0

PUBMED

Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial.

Nosko D, Ferraye MU, Fraix V, Goetz L, Chabardès S, Pollak P, Debû B.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):674-9. doi: 10.1136/jnnp-2013-307511.

0

0

0

PUBMED

Longitudinal study of the substantia nigra in Parkinson disease: A high-field (1) H-MR spectroscopy imaging study.

Seraji-Bozorgzad N, Bao F, George E, Krstevska S, Gorden V, Chorostecki J, Santiago C, Zak I, Caon C, Khan O.

Mov Disord. 2015 Sep;30(10):1400-4. doi: 10.1002/mds.26323.

0

0

0

PUBMED

The significance of motor (a)symmetry in Parkinson's disease.

Marinus J, van Hilten JJ.

Mov Disord. 2015 Mar;30(3):379-85. doi: 10.1002/mds.26107.

0

0

0

PUBMED

Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.

Danti S, Toschi N, Diciotti S, Tessa C, Poletti M, Del Dotto P, Lucetti C.

Eur J Neurol. 2015 Dec;22(12):1564-72. doi: 10.1111/ene.12785.

0

0

0

PUBMED

Impaired cognitive control in Parkinson's disease patients with freezing of gait in response to cognitive load.

Walton CC, Shine JM, Mowszowski L, Gilat M, Hall JM, O'Callaghan C, Naismith SL, Lewis SJ.

J Neural Transm (Vienna). 2015 May;122(5):653-60. doi: 10.1007/s00702-014-1271-6.

0

0

0

PUBMED

Therapeutic cortical-cortical coupling in Parkinson disease.

Alhourani A, Lipski W, Richardson M.

Neurosurgery. 2015 Feb;76(2):N13-4. doi: 10.1227/01.neu.0000460592.48062.9b. No abstract available.

0

0

0

PUBMED

Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease.

Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB.

Mov Disord. 2015 Sep;30(10):1361-70. doi: 10.1002/mds.26269.

0

0

0

PUBMED

Altered brain network centrality in depressed Parkinson's disease patients.

Lou Y, Huang P, Li D, Cen Z, Wang B, Gao J, Xuan M, Yu H, Zhang M, Luo W.

Mov Disord. 2015 Nov;30(13):1777-84. doi: 10.1002/mds.26321.

0

0

0

PUBMED

Subcortical structure volumes and correlation to clinical variables in Parkinson's disease.

Geevarghese R, Lumsden DE, Hulse N, Samuel M, Ashkan K.

J Neuroimaging. 2015 Mar-Apr;25(2):275-80. doi: 10.1111/jon.12095.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy